Novaluron belongs to the trade name, generic name of Repaglinide tablets, long-term fasting blood glucose 8~9mmol/L can be used Repaglinide tablets, but the specific dosage needs to be formulated under the guidance of clinicians. Long-term fasting blood sugar 8~9mmol/L, and accompanied by diabetic symptoms, can be diagnosed as diabetes. For diabetic patients, the goal of glycemic control is generally in the fasting blood glucose 4.4mmol/L ~ 7.0mmol/L, long-term fasting blood glucose 8~9mmol/L generally belongs to the glycemic control does not meet the standard, need to be intervened as soon as possible. Repaglinide is mainly used for adults with type 2 diabetes whose hyperglycemia cannot be effectively controlled by diet control, weight reduction and exercise, and can be used in combination with metformin. Adverse effects: Hypoglycemia, visual abnormalities, abdominal pain, diarrhea, vomiting, and rash may occur after use of the drug. Contraindications: It is contraindicated in patients with type 1 diabetes mellitus, severe hepatic function abnormalities, ketoacidosis, and those who are allergic to the product. Patients should take Repaglinide under the guidance of a doctor and avoid unauthorized medication.